Palisade Bio (PALI) Enterprise Value (2010 - 2026)
Palisade Bio (PALI) reported Enterprise Value of -$129.6 million for Q1 2026, down 1692.12% year-over-year from $8.1 million in Q1 2025, and up 2.14% quarter-over-quarter from -$132.4 million in Q4 2025.
Palisade Bio (PALI) Enterprise Value (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Enterprise Value data on file, last reported at -$129.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$129.6 million, down 1692.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$129.6 million (down 1692.12% YoY), and the FY2025 annual result was -$132.4 million, down 1256.13% from the prior year.
- Enterprise Value climbed to -$129.6 million in Q1 2026 per PALI's latest filing, from -$132.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$5.0 million in Q2 2022 and troughed at -$132.4 million in Q4 2025.
- A 5-year average of -$24.5 million and a median of -$11.4 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value jumped 60.64% in 2022, then plunged 1692.12% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$12.4 million in 2022, then declined by 0.4% to -$12.4 million in 2023, then advanced by 21.47% to -$9.8 million in 2024, then sank by 1256.13% to -$132.4 million in 2025, then advanced by 2.14% to -$129.6 million in 2026.
- Business Quant data shows PALI's Enterprise Value at -$129.6 million in Q1 2026, -$132.4 million in Q4 2025, and -$5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | -129.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.57 Mn |
| Dec 31, 2025 | -132.40 Mn |
| Sep 30, 2025 | -5.23 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Mar 31, 2025 | -7.23 Mn |
| Dec 31, 2024 | -9.76 Mn |
| Sep 30, 2024 | -8.04 Mn |
| Jun 30, 2024 | -11.35 Mn |
| Mar 31, 2024 | -11.28 Mn |
| Dec 31, 2023 | -12.43 Mn |
| Sep 30, 2023 | -15.31 Mn |
| Jun 30, 2023 | -16.40 Mn |
| Mar 31, 2023 | -13.30 Mn |
| Dec 31, 2022 | -12.38 Mn |
| Sep 30, 2022 | -13.99 Mn |
| Jun 30, 2022 | -4.98 Mn |
| Mar 31, 2022 | -6.64 Mn |
| Dec 31, 2021 | -10.50 Mn |
| Sep 30, 2021 | -14.10 Mn |
| Jun 30, 2021 | -12.65 Mn |